Pediatric Onychomycosis Prevalence: A Systematic Review
Onychomycosis, a prevalent nail ailment in adults, has historically been considered rare in children, despite scattered and diverse data. Recent studies, however, hint at an increasing prevalence of onychomycosis in children. This review aimed to address this issue, with two authors individually scouring PubMed, Embase, and Cochrane Library for relevant epidemiological articles. Adhering to PRISMA guidelines, a total of 1042 articles were identified, of which 23 met the eligibility criteria. With one article encompassing two studies, the review eventually included 24 studies. Among these, 17 focused on onychomycosis prevalence in children within the general population, while seven delved into cases among children visiting dermatological and pediatric departments or clinics.
Across these studies, onychomycosis prevalence ranged from 0% to 7.66%. A modest overall increase of 0.66% was observed between 1972 and 2014, although this change wasn’t statistically significant in population studies. This review underscores the emerging trend of elevated onychomycosis prevalence in children, although the limited number of studies warrants caution. Notably, the data suggests that prevalence rises with age, often accompanied by co-infection with tinea pedis, as noted in 25% of the studies.
Trichophyton rubrum emerged as the most common pathogen, mirroring the patterns seen in adults. Moreover, onychomycosis exhibited a greater prevalence in toenails compared to fingernails. This review thus emphasizes that the general characteristics of onychomycosis in children share similarities with those observed in adults.
Fungal infection affecting the nails constitutes a notable portion (15%–40%) of overall nail disorders, prominently impacting adults. While onychomycosis is commonly observed in adults, its occurrence in children has historically been considered uncommon. However, recent indications suggest a potential rise in pediatric onychomycosis over the past few decades. The majority of studies addressing this concern are retrospective and rely on medical records or laboratory data.
Detecting and treating pediatric onychomycosis is of paramount importance for various reasons. Early intervention is critical to halt disease progression, potentially leading to higher cure rates. Mild cases in children can often be effectively managed with topical treatments, which have been FDA-approved for use in those ≥6 or ≥12 years of age, depending on the specific medication.
Notably, topical therapy is deemed more efficacious in children compared to adults, showcasing a lower risk of side effects and systemic exposure. In cases of heightened severity, systemic treatment is introduced, although this approach presents risks of drug interactions and adverse events. Worth mentioning is the lack of licensed systemic antifungal therapy for treating onychomycosis in children.
The primary goal of this systematic review is to delve into the global prevalence of onychomycosis among children. This pursuit is vital in shaping our understanding of the evolving landscape of pediatric onychomycosis and its associated considerations for diagnosis and treatment.
This systematic review focuses on analyzing the prevalence of onychomycosis in the pediatric population (ages 0–18 years), adhering to the PRISMA guidelines for reporting. The review’s registration with PROSPERO was completed on April 11, 2021, with the assigned registration number CRD42021241810. Extensive literature searches were conducted on March 11, 2021, across PubMed, Embase, and Cochrane Library databases.
The search process was diligently carried out by two authors (SVJ & AM) independently, utilizing the literature search tool Rayyan. In cases of disagreement between the authors, the senior author (DMS) was consulted for resolution. This meticulous approach ensures the review’s comprehensiveness and adherence to established guidelines, ultimately contributing to the robustness of the findings.
The inclusion criteria for this study involved selecting peer-reviewed articles published in English or Danish, specifically focusing on onychomycosis prevalence in children. To ensure statistical significance, only studies encompassing 100 or more children under the age of 18 were considered eligible. This rigorous approach aimed to provide a comprehensive and reliable understanding of onychomycosis prevalence within the pediatric population.
This study’s scope excluded research involving specific patient groups like those with diabetes or immunodeficiency. Additionally, studies where the entire population had pre-existing onychomycosis or superficial mycosis upon study entry were not considered. The review also disregarded studies centered on a single causal agent or those conducting laboratory surveys of specimens from suspected onychomycosis patients. This rigorous exclusion criteria ensured that the study’s findings remained focused on general prevalence trends within the target pediatric population.
The review involved the extraction of relevant data by a designated researcher (SVJ) onto a prearranged Excel sheet. This data encompassed onychomycosis prevalence, publication year, country of origin, study population specifics, diagnostic methods employed, and additional factors such as prevalence comparison between fingernails and toenails, risk factors, etiological agents, and concomitant mycosis or skin diseases. A narrative synthesis approach was taken for data reporting due to the heterogeneity in study designs, precluding meta-analysis. To assess the relationship between time and onychomycosis prevalence, linear regression was applied using RStudio Version 1.2.1335, contributing to a comprehensive evaluation of potential trends over time.
This systematic review encompassed a total of 1042 articles from databases including Embase, PubMed, and Cochrane Library. After eliminating duplicates (237), 805 articles underwent screening. Among these, 680 were considered unrelated, leading to a closer examination of 125 articles. Eventually, 23 articles with 24 studies were deemed suitable for inclusion.
The analyzed studies spanned a 44-year period and encompassed 17 studies exploring onychomycosis prevalence in the general population and seven focusing on pediatric or dermatological clinics or departments. In population-based studies, onychomycosis prevalence among children ranged from 0% to 3.37%, whereas studies from clinics or departments exhibited prevalence varying from 0% to 0.53%, based on clinical observation, microscopy, and culture.
Participant numbers varied significantly, from 100 to 32,235 children. Most participants in population-based studies were aged 5 to 16 years, while those in clinics or departments spanned ages 0 to 18 years. Gender-wise, males constituted 44.7% to 100%, with a mean prevalence of 51.9% (28,507 male children out of 65,189). A study indicated that boys had a higher likelihood of onychomycosis than girls (p = 0.001, male frequency: 54.5%).
Clinical diagnosis was common across studies, often confirmed by microscopy and culture (17/24). Prevalence ranged from 0% to 3.37% for combined clinical diagnosis, microscopy, and culture. Additionally, studies relying on clinical diagnosis and microscopy only had prevalence rates between 0% and 0.25%. Some solely relied on clinical diagnosis, yielding rates of 0.03% to 7.66%, with the highest rates recorded in studies from the Solomon Islands (7.66%), Ethiopia (7.59%), and Brazil (5.01%).
Over time, the prevalence of onychomycosis showed a notable increase, with rates rising from 0.22% in 1972 to 0.29% to 0.88% in 2014-2016. For onychomycosis prevalence in Turkey, six studies from 2002 to 2013 indicated rates of 0% to 0.33%, with a slight uptick from 2004 to 2013.
Geographical distribution was wide-ranging, spanning multiple continents. Notably, the highest prevalence was mycologically confirmed at 3.37% in a 2009 Peruvian study. Similarly, Mexico (0.75%), Israel (0.87%), and Nigeria (0.88%) reported high prevalence rates. Clinical diagnoses only, prevalent in some studies, exhibited higher rates, such as Ethiopia (7.59%) and the Solomon Islands (7.66%). Geographically, Europe (0% to 0.20%), North America (0% to 0.75%), and West Asia (0% to 0.87%) showcased varying prevalence ranges.
Some studies reported concomitant infections on other body sites (tinea pedis or tinea capitis), while dermatophytes were more common than yeasts. T. rubrum was the predominant dermatophyte species, while common yeasts included C. albicans and C. glabrata. The distribution of onychomycosis in fingernails versus toenails was also examined, indicating varying prevalence in different studies.
In summary, this systematic review showcased an apparent increase in onychomycosis prevalence among children over time. It also highlighted the significance of accurate diagnostic methods and the influence of geography, age, and gender on prevalence rates.
This systematic review provides evidence suggesting a potential rise in the prevalence of onychomycosis among children, particularly during the years 2000-2015. However, this trend lacks statistical significance based on available data. Diagnostic accuracy holds paramount importance in the pediatric population, as only around 15.5% of nail issues in children are attributed to onychomycosis. The majority of studies (83% out of 24) confirmed onychomycosis suspicion through mycological examination.
Despite variations in sampling methods, participant numbers, gender, cultural factors like footwear and sports, the prevalence data seem relatively consistent. The initial hypothesis of higher prevalence rates in dermatology centers and clinics than in background populations was not substantiated. The variation in age groups examined, warmer geographical locations, and potential confounders like footwear and access to healthcare may impact prevalence rates.
Onychomycosis tends to be more common in toenails than fingernails in both children and adults. The transfer from tinea pedis to toenails, observed in adult studies, is supported by findings where tinea pedis and onychomycosis coexist. The most prevalent pathogen identified is T. rubrum, consistent with findings in adults. Yeast-caused onychomycosis is more prevalent in fingernails, particularly in immunosuppressed individuals and neonates. Curiously, most yeast-related cases in supposedly healthy school children were found in toenails.
Exploring factors like moist shoe environments, genetic predisposition, and diabetes as associated factors would be insightful. The review highlights certain limitations, including population size requirements, age group differences, and incomplete testing for various pathogens.
In conclusion, this systematic review indicates a potential increase in onychomycosis prevalence among children, although not statistically significant with available data. It emphasizes the importance of considering childhood onychomycoses, especially when concurrent tinea pedis is present. The prevalent pathogen, T. rubrum, and the higher prevalence of toenail infection compared to fingernails are notable observations.
Oncology Related Tools
- Prognostic Scoring for Myelofibrosis
- Opioid Conversion Calculator
- Updated Advanced Opioid Conversion Calculator
- Nonsteroidal anti-inflammatory drugs (NSAID) Selection Tool
- Absolute Neutrophil Count Calculator
- Body Surface Area (BSA) Multi-Calc
- Carboplatin AUC Calculator
- Carboplatin AUC – Updated Version
- Urinary Indices, Renal Failure Index (RFI) and Fractional Excretion of Sodium (FE-NA)
- Creatinine Clearance (CRCL) – Standard Calculator
- Creatinine Clearance Multi-Calc – All of the latest research
- Patient Controlled Analgesia (PCA) Settings
- Intravenous Antineoplastic Agents – Administration Guidelines
- Therapeutic Drug Levels
- Beers Criteria for potentially inappropriate medications
- Allergic response? 12-step desensitization protocol
- Protein requirements calculator
- Basal Metabolic Rate (BMR) Multi-calc (Estimate caloric requirements)
- Irritable Bowel Syndrome Treatment Options
- Common Anti-emetics
- Fall Assessment – Berg Balance Scale
- Hormone Disturbances In Migraine Disorder: A Meta-Analysis
- IGF-1 Levels In Pediatric Low-Level Gliomas
- Visual Field Defects In Patients With Pituitary Tumors
- Chronic Spontaneous Urticaria: Studying Age-Specific Therapies
- Levothyroxine Treatment In Patients With Thyroid Cancer
- Ocular Surgery In Infants And Post-Op Eye Drop Risks
- Cancer Care: Gender Bias In Decision-Making
- Respiratory Syncytial Virus Infection: A Tool For Assessing Clinical Severity
- Gynecologic Cancer Survivors: A Study Of Lifestyle Factors
- Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk
- Antithyroid Drug Therapy And Cardiovascular Morbidity
- Eosinophilic Dermatosis In Hematological Malignancy (EDHM): Case Study Reports
- Uterine Leiomyosarcoma: A-Meta Analysis Of Systemic Therapy Effectiveness
- Off-Label Medication Use In Oncology
- Monocytosis And Patient Risk Of Malignancy And Mortality
- Bedside Pediatric Early Warning System: A Validation Study
- Chronic Hyponatremia In Heart Failure
- Massage Therapy For Oncology Patient Pain
- Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
- Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy
- Acute Myeloid Leukemia And Diverse Patient Survival Outcomes
- Sarcopenia And Chronic Kidney Disease
- Childhood Obesity: Targeted Dietary Interventions
- Supragastric Belching And Acid Reflux Severity
- Diabetic Peripheral Neuropathy Diagnosis Using Nerve Ultrasonography
- IBD: A Link To Cancer And Infection
- Renal Transplant Risks With Prostate Cancer
- COPD Risk With Diabetes And Pre-Diabetes
- Urothelial Carcinoma – Uretal And Renal Pelvic Tumors
- Merkel Cell Carcinoma: A Case Of Metastasis To The Tonsils
- Infant Formula Protein Content And Childhood Obesity
- Maternal Migraines And Associated Pediatric Cancers
- Pediatric Neuroblastoma Diagnosis Using Urinary Catecholamine Metabolites
- Finerenone Therapy In CKD And Type 2 Diabetes
- Binge Eating Habits And Diabetic Implications
- Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases
- Melanoma Diagnosis Without Biopsy
- Pediatric Opioids And Pain Control In Fractures
- Daikenchuto Treatment For Chronic Constipation
- Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education
- Autistic Adults: A Study On Cognitive Therapy Experiences
- The Impact Of Long-Term Opioid Treatment On Endocrine Parameters
- Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis
- Diabetes Mellitus During The Pandemic
- Carfilzomib Therapy In Pediatric Acute Lymphoblastic Leukemia
- Golimumab Compliance In Long-Term Arthritis Treatment
- Medullary Thyroid Cancer And Vocal Cord Paralysis
- Primary Adenocarcinoma Of The Orbit: A Case Study
- Survival Trends: Pancreatic Cancer in the USA
- Nusinersen Therapy For Pediatric Spinal Muscular Atrophy
- Pediatric Liver Transplantation: A New Biological Abdominal Wall
- Influenza Surveillance: A Review Of Data Sources
- Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
- Dry Eye Disease And Dehydration
- Macular Edema Therapy Using Dexamethasone Nanoparticle Suspension
- Colorectal Cancer Screening For Older Adults
- Satiation And Satiety: An Overview And Clinical Calculator
- Cholesterol Screening To Aid In Glaucoma Detection
- Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors
- Olfactory Dysfunction and Screening For Depression: A QOL Study
- Cancer Diagnosis And Mental Health
- Mental Health Screening In Psoriatic Arthritis Patients
- Prostate Cancer: A New Biopsy Risk Calculator Using MRI
- Mental Health Study in Cancer Survivors
- Mental Health Screening In The Community
- Bone Mineral Density Screening Combined With Mammography
- Bone Mineral Density In Type 1 Diabetes Mellitus
- Cochlear Implants and Vestibular Screening
- Aprocitentan In Resistant Hypertension
- Predicting Cardiovascular Disease With Body Mass Index
- Obesity Screening To Predict Hot Flashes
- Hypertension Screening For Cardiovascular Health
- Dental Screening For Cardiovascular Disease Risk
- Blood Pressure and CVD Risk Reduction
- Lifestyle Changes For Hypoglycemia Prevention
- Ovarian Adenocarcinoma With Glaucoma: A Case Report
- Community Hypertension and Atherosclerosis Risk
- Thyroid Malignancy and Serum Calcitonin
- Rare Schwannoma In Lateral Nasal Wall
- Pyrotinib Therapy In HER2+ Breast Cancer
- Osteopenia Predicts Outcomes in Pancreatic Cancer
- Outcomes of Physical Exercise Regimens in Advanced Cancer
- Penile Squamous Cell Carcinoma And HPV
- Radiation Therapy And VTE Risk
- Pseudouveitis With Pancreatic Carcinoma: A Case Study
- Cancer Prevention In Rural Communities
- Skeletal Muscle Mass and Cancer Patient Quality of Life: A Meta-Analysis
- Incidence of Secondary Cancers After CIRT VS RT
- Filanesib Combination Therapy in Multiple Myeloma
- Pediatric Leukemia Patients Utilizing Levofloxacin
- Breast Cancer And An Analysis Of Cardiovascular Events
- Monotherapy Or Chemotherapy Adjunct: Pembrolizumab in Advanced NSCLC
- Advanced Gastric Cancer: Prognosis with Nivolumab Monotherapy
- Sinonasal B‐Cell Lymphomas A Cohort Study On Progression And Recurrence
- Platinum Resistant Recurrent Ovarian Cancer Treatment+/-Bevacizumab
- Metastatic Melanoma and Follow-Up MRI Scans
- Isatuximab Treatment in Refractory T-Acute Lymphoblastic Leukemia
- Ocular Melanoma and Treatment with Metformin
- Gastric Neuroendocrine Neoplasms
- Lung Cancer with Brain Metastasis After Late-Onset Bipolar Disorder: A Case Report
- Anlotinib with Camrelizumab in Lung Cancer Treatment
- Sebaceous Carcinoma Treatment Outcomes: A Multicenter Study
- Diffuse-Type Tenosynovial Giant Cell Tumors: Treatment and Progression
- Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report
- DNA Methylation Profiling in Sarcoma Classification
- Breast Tomosynthesis Simulator For Virtual Clinical Trials
- Renal Cell Carcinoma-Prognosis Via Albumin Levels
- Diagnostic Error Causing Cases of Cytopenia
- Hodgkin’s Lymphoma: A Case Study With Nystagmus and Diplopia
- Brugada Syndrome Treated with Lenalidomide: A Case Study
- Koolen-de Vries Case Study
- Suicidal Ideation and Somatic Treatments
- Study on Pavlovian Fear Conditioning and Fear Reversal in OCD
- Anxiety Scales in Lewy Body Disease
- Inoperable Locally Advanced Non-Small Cell Lung Cancer: Survival Rates of Endostar, CCRT
- Physician Practice Management and Private Equity
- Physician Spending And Its Association With Patient Outcomes
- Physician Burnout: Causes and Prevention
- LEAP-MS: Adaptations for Advanced Stages
- MS: Exercise Impacts on MRI
- The Role of Preretirement Job Complexity in Cognitive Performance
- Extrapontine Myelinolysis and PTA in Pregnancy
- Verbal Communication and Masks
- Sugammadex Versus Neostigmine in Thyroidectomy
- SGLT Inhibitors on Weight and Lipid Metabolism in Diabetes
- Saxagliptin: Obese Patients with Impaired Glucose Tolerance
- Levothyroxine Therapy and Depression
- Grave’s Disease and Risk of Systemic Lupus Erythematosus
- Benign Thyroid Removal and Patient Satisfaction
- MF- Biology, Management, and a Case Study of Ocular Manifestation
- Quality Of Life In Adolescent Cancer Survivors
- Cancer Opioid Risk Score
- Oncology-Specific Opioid Risk Calculator In Cancer Survivors
- 3D MRI for Non-invasive Ocular Proton Therapy of Uveal Melanomas
- Sexual Dysfunction in Prostate Cancer Patients
- 3-Day Surprise Question To Predict Survival Rates in Advanced Cancer Patients